To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care
Description
What are the main indicators that a patient with multiple sclerosis (MS) can be switched to a biosimilar?
Credit available for this activity expires: 5/31/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000864?ecd=bdc_podcast_libsyn_mscpedu
Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation.
Credit available for this activity expires: 10/29/25
Earn Credit / Learning Objectives & Disclosures:...
Published 10/29/24
Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD).
Credit available for this activity expires: 10/28/25
Earn Credit / Learning Objectives & Disclosures: ...
Published 10/29/24